Actin‐like 6A predicts poor prognosis of hepatocellular carcinoma and promotes metastasis and epithelial‐mesenchymal transition
Shuai Xiao, Rui‐Min Chang, Ming‐Yang Yang, Xiong Lei, Xiao Liu, Wen‐Bin Gao, Jing‐Lei Xiao, Lian‐Yue Yang – 23 December 2015 – Hepatocellular carcinoma (HCC) is one of the most lethal cancers worldwide because of metastasis. Epithelial‐mesenchymal transition (EMT) is widely considered to be crucial to the invasion‐metastasis cascade during cancer progression. Actin‐like 6A (ACTL6A) is initially verified important for cell proliferation, differentiation, and migration. In this study, we find that ACTL6A plays an essential role in metastasis and EMT of HCC.